Previous 10 | Next 10 |
2023-11-09 09:07:00 ET U.S. stock index futures on Thursday pointed to a marginally higher open, amid a week that has largely seen small moves in equities in light of a dearth of economic data. The third quarter earnings season continued to garner a chunk of attention, with Walt Disney ...
2023-11-09 08:30:31 ET COVID-19 vaccine maker Novavax ( NASDAQ: NVAX ) reported better than expected financials for Q3 2023 on Thursday as its grants from the U.S. government reached $164.9M, marking ~55% growth from last year due mainly to support activities and milestones. How...
2023-11-09 08:04:40 ET More on Novavax Moderna Vs. Novavax: Neither Offering Short-Term Value As Fall Vaccine Season Begins Novavax's COVID-19 Investment Thesis Is Old News Novavax COVID vaccine in focus ahead of Q3 earnings For further details see: Novav...
Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights PR Newswire Received authorization from the U.S. FDA and approval from the European Commission for the Company's updated COVID-19 vaccine, and launched the only protein-based non-mRNA vaccine opt...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Novavax Inc. (NVAX) is expected to report $-1.82 for Q3 2023
2023-11-08 11:30:02 ET Novavax ( NASDAQ: NVAX ) remains a distant third in the COVID immunization drive as the company prepares to release its Q3 2023 results on Thursday before the opening bell, with investors closely watching updates on its recently launched COVID shot. In Oct...
2023-11-06 09:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-05 23:46:57 ET In the upcoming week of November, investors can anticipate a flurry of quarterly reports from major companies, promising significant market activity. Notable among them is Disney ( NYSE: DIS ), a household name set to disclose its financial performance. ...
2023-11-03 07:44:52 ET Novavax (NASDAQ: NVAX) stock price has been a huge disappointment among investors in the past few months. After peaking at $332 during the Covid-19 pandemic, the shares have tumbled to $7. They are now trading at an all-time low while the short interest has jumped...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...